Is BHA safe in cosmetics?
BHA has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 10 toxicological study endpoint(s) are available in our database. This ingredient has been reviewed by SCCS Opinion.
Also known as: (1,1-Dimethylethyl)-4-methoxyphenol, 1,1-(Dimethylethyl)-4-methoxyphenol, Phenol, tert-butyl-4-methoxy-, terc-butil-4-metoxifenol, tert-Butyl-4-hydroxyanisole (+14 more)
BHA (CAS 25013-16-5) is a cosmetic antioxidant functioning as Antioxidant; synthetic chain-breaking free radical scavenger (SET/HAT. NOAEL 50 mg/kg bw/day (PDF-verified against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 0.07%; 5 safety opinions reviewed (SCCS Opinion). Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and food safety data.
View industrial chemical safety profile for CAS 25013-16-5 →
BHA is classified GHS CMR hazard (H302, H315, H319, H335, H351, H361, H361f, H411) in the chemicals database but is restricted in EU cosmetics at max 0.07%.
Source: Cosmetics: ingredients.eu status/eu max; Chemicals: ghs classifications.signal word/hazard statement code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for BHA.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for BHA. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =220 mg/kg/d | oral | rat | reproductive toxicity | CIR Safety Assessment |
| NOAEL | =220 mg/kg/d | oral | rat | reproductive toxicity | CIR Safety Assessment |
| NOAEL | =220 mg/kg/d | oral | rat | reproductive toxicity | CIR Safety Assessment |
| NOAEL | =220 mg/kg/d | oral | rat | reproductive toxicity | CIR Safety Assessment |
| NOAEL | =420 mg/kg/d | oral | rat | reproductive toxicity | CIR Safety Assessment |
| NOAEL | =420 mg/kg/d | oral | rat | reproductive toxicity | CIR Safety Assessment |
| NOAEL | =420 mg/kg/d | oral | rat | reproductive toxicity | CIR Safety Assessment |
| NOAEL | =420 mg/kg/d | oral | rat | reproductive toxicity | CIR Safety Assessment |
| NOAEL | 50 mg/kg bw/day | oral | swine | Subchronic | COSMOS DB |
| NOAEL | 60 mg/kg bw/day | oral | dog | Subchronic | COSMOS DB |
Official safety assessments from the Scientific Committee on Consumer Safety (SCCS) and Cosmetic Ingredient Review (CIR).
Pre-calculated NOAEL → SED → MoS audit trail for BHA across SCCS product categories, with measured dermal absorption where available.
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| cancer slope factor | =0.0002 (mg/kg-day)-1 | Human | inhalation | chronic | Cal OEHHA |
| cancer slope factor | =0.0002 (mg/kg-day)-1 | Human | oral | chronic | Cal OEHHA |
| NOAEL | =100 mg/kg-day | Rat | oral | - | EFSA |
| NOAEL | =100 mg/kg-day | Rat | oral | - | EFSA |
| NOAEL | =100 mg/kg-day | Rat | oral | - | EFSA |
| LOEL | =500 mg/kg-day | Mouse | oral | acute | ECOTOX |
| NOEL | =100 mg/kg-day | Mouse | oral | acute | ECOTOX |
| LOEL | =2 % | Rat | oral | subchronic | ECOTOX |
| NOEL | =2 % | Rat | oral | subchronic | ECOTOX |
| LOEL | =2 % | Rat | oral | subchronic | ECOTOX |
International Agency for Research on Cancer (WHO) monograph evaluation.
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
mixed agonist/antagonist (ER); antagonist (AR, weak)
| Endpoint | Target | Value | Direction |
|---|---|---|---|
| EC_testicular | reproductive | 100 µM — abnormal testicular formation (mice) µM | agonist |
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| CN | restricted | 0.5 | All cosmetics (antioxidant use) |
| AU | restricted | - | antioxidants |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 2.68 | In vitro; human skin; 16h continuous | Human skin in vitro | SCCS/0306 BHA opinion; CIR 2024 (2024) |
| default | 50.0 | method=default | - | - |
| measured | 0.07 | method=measured | - | - |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Body Lotion | 0.01–0.1 | 0.5 | CIR Safety Assessment |
1 property record from structured ingredient metadata.
Expert safety assessment and concern-level summary for BHA.
Public NOAEL study rows linked to BHA by CAS number or substance name.
Units vary across source rows: mg/kg bw/d, mg/kg bw/day, mg/kg/d
| Absorption % | Method | Vehicle |
|---|---|---|
| 2.68 | In vitro; human skin; 16h continuous | 0.07% BHA solution |
| 50.0 | method=default | - |
| 0.07 | method=measured | - |
Same-CAS public records found in food safety data.
Same-CAS food additive or FDA GRAS records from the core public database.
BHA has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 10 toxicological study endpoint(s) are available in our database. This ingredient has been reviewed by SCCS Opinion.
BHA EU regulatory status: restricted. Maximum allowed concentration: 0.07%. This is based on EU Regulation 1223/2009 and its amendments.
BHA functions as: Antioxidant; synthetic chain-breaking free radical scavenger (SET/HAT mechanism); product preservative against oxidative degradation in oils and waxes. It is classified as a Antioxidant in our database. CAS number: 25013-16-5.
The NOAEL (No Observed Adverse Effect Level) for BHA is =220 mg/kg/d based on a reproductive toxicity study via oral route in rat. A total of 10 study endpoints are available. Source: CIR Safety Assessment.
BHA also appears in industrial chemical safety and food safety data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
BHA is classified GHS CMR hazard (H302, H315, H319, H335, H351, H361, H361f, H411) in the chemicals database but is restricted in EU cosmetics at max 0.07%.
Check BHA compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for BHA in your formulation.